Clinical Trial Update: Design and Validation of Plasma Proteins and Cytokine Panels to Identify Markers Associated With Response to Niraparib as Maintenance Treatment After First-line Platinum-based Regimen in Patients With Advanced Ovarian Cancer

View source ↗

Summary

A protocol-level study to design and validate plasma protein and cytokine panels to identify biomarkers associated with response to Niraparib as maintenance the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Advanced Ovarian Cancer | Status: NOT_YET_RECRUITING